{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:00:20Z","timestamp":1792515620703,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360103"],"award-info":[{"award-number":["82360103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U21A20343"],"award-info":[{"award-number":["U21A20343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2022AAC03573"],"award-info":[{"award-number":["2022AAC03573"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atherogenic index of plasma (AIP) is a non-traditional lipid parameter that can reflect the burden of atherosclerosis. A lipid profile resembling atherosclerosis emerged during pregnancy. Although lipid metabolism is pivotal in diabetes pathogenesis, there is no evidence linking AIP to gestational diabetes mellitus (GDM). Therefore, our objective was to explore the relationship between AIP and GDM and assess AIP's predictive capability for GDM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a secondary analysis based on data from a prospective cohort study in Korea involving 585 single pregnant women. AIP was calculated as log10 (TG\/HDL). We examined the relationship between AIP and GDM using logistic regression models, curve fitting, sensitivity analyses, and subgroup analyses. Receiver operating characteristic (ROC) analysis was also used to determine the ability of AIP to predict GDM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average age of the participants was 32.06\u2009\u00b1\u20093.76\u00a0years. The AIP was 0.24\u2009\u00b1\u20090.20 on average. The GDM incidence was 6.15%. After adjustment for potentially confounding variables, AIP showed a positive linear relationship with GDM (<jats:italic>P<\/jats:italic> for non-linearity: 0.801, OR 1.58, 95% CI 1.27\u20131.97). The robustness of the connection between AIP and GDM was demonstrated by sensitivity analyses and subgroup analyses. An area under the ROC curve of 0.7879 (95% CI 0.7087\u20130.8671) indicates that AIP is an excellent predictor of GDM. With a specificity of 75.41% and sensitivity of 72.22%, the ideal AIP cut-off value for identifying GDM was 0.3557.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study revealed that the AIP at 10\u201314\u00a0weeks of gestation was independently and positively correlated with GDM risk. AIP could serve as an early screening and monitoring tool for pregnant women at high risk of GDM, thereby optimizing GDM prevention strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov registration no. NCT02276144.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12933-024-02341-9","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:01:47Z","timestamp":1720202507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Association between atherogenic index of plasma and gestational diabetes mellitus: a prospective cohort study based on the Korean population"],"prefix":"10.1186","volume":"23","author":[{"given":"Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weining","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yideng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"2341_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.diabres.2013.10.012","volume":"103","author":"M Agarwal","year":"2014","unstructured":"Agarwal M, Boulvain M, Coetzee E, Colagiuri S, Falavigna M, Hod M, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103:341\u201363.","journal-title":"Diabetes Res Clin Pract"},{"key":"2341_CR2","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.3390\/jcm11195736","volume":"11","author":"R Modzelewski","year":"2022","unstructured":"Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational diabetes mellitus\u2014recent literature review. JCM. 2022;11:5736.","journal-title":"JCM"},{"key":"2341_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","volume":"43","author":"A Sweeting","year":"2022","unstructured":"Sweeting A, Wong J, Murphy HR, Ross GP. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43:763\u201393.","journal-title":"Endocr Rev"},{"key":"2341_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"B Metzger","year":"2008","unstructured":"Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991\u20132002.","journal-title":"N Engl J Med"},{"key":"2341_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12933-019-0935-9","volume":"18","author":"A Lorenzo-Almor\u00f3s","year":"2019","unstructured":"Lorenzo-Almor\u00f3s A, Hang T, Peir\u00f3 C, Soriano-Guill\u00e9n L, Egido J, Tu\u00f1\u00f3n J. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18:140.","journal-title":"Cardiovasc Diabetol"},{"key":"2341_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11892-019-1267-6","volume":"19","author":"ME Bianco","year":"2019","unstructured":"Bianco ME, Josefson JL. Hyperglycemia during pregnancy and long-term offspring outcomes. Curr Diab Rep. 2019;19:143.","journal-title":"Curr Diab Rep"},{"key":"2341_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"A Lapolla","year":"2010","unstructured":"Lapolla A, Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P, Dyer A, Leiva A, Hod M, Kitzmiler J. International Association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676\u201382.","journal-title":"Diabetes Care"},{"key":"2341_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2018.09.003","volume":"144","author":"H Abokaf","year":"2018","unstructured":"Abokaf H, Shoham-Vardi I, Sergienko R, Landau D, Sheiner E. In utero exposure to gestational diabetes mellitus and long term endocrine morbidity of the offspring. Diabetes Res Clin Pract. 2018;144:231\u20135.","journal-title":"Diabetes Res Clin Pract"},{"key":"2341_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.12669\/pjms.35.1.216","volume":"35","author":"P Li","year":"2019","unstructured":"Li P, Lin S, Li L, Cui J, Zhou S, Fan J. First-trimester fasting plasma glucose as a predictor of gestational diabetes mellitus and the association with adverse pregnancy outcomes. Pak J Med Sci. 2019;35:95\u2013100.","journal-title":"Pak J Med Sci"},{"key":"2341_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1s\u0306ov\u00e1","year":"2001","unstructured":"Dobi\u00e1s\u0306ov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34:583\u20138.","journal-title":"Clin Biochem"},{"key":"2341_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","volume":"9","author":"X-W Zhu","year":"2015","unstructured":"Zhu X-W, Deng F-Y, Lei S-F. Meta-analysis of atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9:60\u20137.","journal-title":"Prim Care Diabetes"},{"key":"2341_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00592-021-01801-y","volume":"59","author":"Q Yi","year":"2021","unstructured":"Yi Q, Ren Z, Bai G, Zhu S, Li S, Li C, et al. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese. Acta Diabetol. 2021;59:269\u201379.","journal-title":"Acta Diabetol"},{"key":"2341_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-023-01740-8","volume":"22","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wen M. Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011\u20132018 population. Cardiovasc Diabetol. 2023;22:19.","journal-title":"Cardiovasc Diabetol"},{"key":"2341_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","volume":"62","author":"SM Lee","year":"2018","unstructured":"Lee SM, Kwak SH, Koo JN, Oh IH, Kwon JE, Kim BJ, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2018;62:238\u201348.","journal-title":"Diabetologia"},{"key":"2341_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221400","volume":"14","author":"SM Lee","year":"2019","unstructured":"Lee SM, Kim BJ, Koo JN, Norwitz ER, Oh IH, Kim SM, et al. Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. PLoS ONE. 2019;14: e0221400. https:\/\/doi.org\/10.1371\/journal.pone.0221400","journal-title":"PLoS ONE"},{"issue":"5","key":"2341_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2213-8587(23)00062-1","volume":"11","author":"A Bardugo","year":"2023","unstructured":"Bardugo A, Bendor CD, Rotem RS, et al. Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study. Lancet Diabetes Endocrinol. 2023;11(5):333\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2341_CR17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2337\/dc21-2634","volume":"45","author":"CD Bendor","year":"2022","unstructured":"Bendor CD, Bardugo A, Rotem RS, et al. Glucose intolerance in pregnancy and offspring obesity in late adolescence. Diabetes Care. 2022;45(7):1540\u20138.","journal-title":"Diabetes Care"},{"key":"2341_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487\u201395.","journal-title":"Diabetes Care"},{"key":"2341_CR19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. 2022;18:760\u201375.","journal-title":"Nat Rev Endocrinol"},{"key":"2341_CR20","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"AB Caughey","year":"2018","unstructured":"Caughey AB, Turrentine M. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49-64.","journal-title":"Obstet Gynecol"},{"key":"2341_CR21","first-page":"36","volume":"628","author":"K-S Kim","year":"2021","unstructured":"Kim K-S, Hong S, Han K, Park C-Y. The clinical characteristics of gestational diabetes mellitus in Korea: A National Health information database study. Endocrinol Metab. 2021;628:36.","journal-title":"Endocrinol Metab"},{"key":"2341_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00125-016-3979-3","volume":"59","author":"C Zhang","year":"2016","unstructured":"Zhang C, Rawal S, Chong YS. Risk factors for gestational diabetes: is prevention possible? Diabetologia. 2016;59:1385\u201390.","journal-title":"Diabetologia"},{"key":"2341_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100830","volume":"34","author":"J Hu","year":"2021","unstructured":"Hu J, Gillies CL, Lin S, Stewart ZA, Melford SE, Abrams KR. Association of maternal lipid profile and gestational diabetes mellitus: a systematic review and meta-analysis of 292 studies and 97,880 women. EClinicalMedicine. 2021;34: 100830.","journal-title":"EClinicalMedicine"},{"key":"2341_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1515\/med-2021-0408","volume":"17","author":"FA Rahnemaei","year":"2021","unstructured":"Rahnemaei FA, Pakzad R, Amirian A, Pakzad I, Abdi F. Effect of gestational diabetes mellitus on lipid profile: a systematic review and meta-analysis. Open Med (Wars). 2021;17:70\u201386.","journal-title":"Open Med (Wars)"},{"key":"2341_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mam.2017.01.007","volume":"55","author":"A Leiva","year":"2017","unstructured":"Leiva A, Guzm\u00e1n-Guti\u00e9rrez E, Contreras-Duarte S, Fuenzalida B, Cantin C, Carvajal L. Adenosine receptors: modulators of lipid availability that are controlled by lipid levels. Mol Asp Med. 2017;55:26\u201344.","journal-title":"Mol Asp Med"},{"key":"2341_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00404-020-05738-5","volume":"303","author":"S Niyaty","year":"2020","unstructured":"Niyaty S, Moghaddam-Banaem L, Sourinejad H, Mokhlesi S. Are maternal metabolic syndrome and lipid profile associated with preterm delivery and preterm premature rupture of membranes? Arch Gynecol Obstet. 2020;303:113\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"2341_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1590\/1806-9282.65.12.1489","volume":"65","author":"MDCP Lima","year":"2019","unstructured":"Lima MDCP, Melo ASO, Sena ASS, Barros VDO, Amorim MMR. Metabolic syndrome in pregnancy and postpartum: prevalence and associated factors. Rev Assoc Med Bras. 2019;65:1489\u201395.","journal-title":"Rev Assoc Med Bras"},{"key":"2341_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12916-020-01868-4","volume":"18","author":"MC Adank","year":"2020","unstructured":"Adank MC, Benschop L, van Streun SP, Smak Gregoor AM, Mulder MT, Steegers EAP, et al. Gestational lipid profile as an early marker of metabolic syndrome in later life: a population-based prospective cohort study. BMC Med. 2020;18:394.","journal-title":"BMC Med"},{"key":"2341_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MOL.0000000000000927","volume":"35","author":"JWCM Mulder","year":"2024","unstructured":"Mulder JWCM, Kusters DM, Roeters van Lennep JE, Hutten BA. Lipid metabolism during pregnancy: consequences for mother and child. Curr Opin Lipidol. 2024;35:133\u201340.","journal-title":"Curr Opin Lipidol"},{"key":"2341_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12884-022-04524-2","volume":"22","author":"CW Waage","year":"2022","unstructured":"Waage CW, Mdala I, Stigum H, Jenum AK, Birkeland KI, Shakeel N, et al. Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity. BMC Pregnancy Childbirth. 2022;22:246.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2341_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.diabres.2005.03.022","volume":"70","author":"DA Enquobahrie","year":"2005","unstructured":"Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract. 2005;70:134\u201342.","journal-title":"Diabetes Res Clin Pract"},{"key":"2341_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12967-023-04322-0","volume":"21","author":"Y Gao","year":"2023","unstructured":"Gao Y, Hu Y, Xiang L. Remnant cholesterol, but not other cholesterol parameters, is associated with gestational diabetes mellitus in pregnant women: a prospective cohort study. J Transl Med. 2023;21:531.","journal-title":"J Transl Med"},{"key":"2341_CR33","first-page":"633","volume":"09","author":"B Yin","year":"2004","unstructured":"Yin B, Xi Z, Chen S, Wei R. Study on the risk factors of coronary heart disease with comprehensive index of blood lipid. J Clin Intern Med. 2004;09:633\u20134.","journal-title":"J Clin Intern Med"},{"key":"2341_CR34","first-page":"16","volume":"09","author":"G Hong","year":"2007","unstructured":"Hong G. The relationship between lipid comprehensive index and coronary heart disease with diabets mellitus. Qinghai Med J. 2007;09:16\u20137.","journal-title":"Qinghai Med J"},{"key":"2341_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285\u201394.","journal-title":"Arch Med Res"},{"key":"2341_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","volume":"22","author":"B Yin","year":"2023","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22:157.","journal-title":"Cardiovasc Diabetol"},{"key":"2341_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12933-023-01934-0","volume":"22","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhang X, Han Y, Hu H, Cao C. Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol. 2023;22:205.","journal-title":"Cardiovasc Diabetol"},{"key":"2341_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13098-023-00992-4","volume":"15","author":"X Wu","year":"2023","unstructured":"Wu X, Gao Y, Wang M, Peng H, Zhang D, Qin B, et al. Atherosclerosis indexes and incident T2DM in middle-aged and older adults: evidence from a cohort study. Diabetol Metab Syndr. 2023;15:23.","journal-title":"Diabetol Metab Syndr"},{"key":"2341_CR39","doi-asserted-by":"publisher","first-page":"26548","DOI":"10.1038\/srep26548","volume":"6","author":"A Wang","year":"2016","unstructured":"Wang A, Chen G, Su Z, Liu X, Liu X, Li H, et al. Risk scores for predicting incidence of type 2 diabetes in the Chinese population: the Kailuan prospective study. Sci Rep. 2016;6:26548.","journal-title":"Sci Rep"},{"key":"2341_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1463-1326.2012.01607.x","volume":"14","author":"SH Ley","year":"2012","unstructured":"Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ. Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012;14:821\u20135.","journal-title":"Diabetes Obes Metab"},{"key":"2341_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s42000-018-0014-8","volume":"17","author":"VG Athyros","year":"2018","unstructured":"Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, et al. Diabetes and lipid metabolism. HJ. 2018;17:61\u20137.","journal-title":"HJ"},{"key":"2341_CR42","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"U Jung","year":"2014","unstructured":"Jung U, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. IJMS. 2014;15:6184\u2013223.","journal-title":"IJMS"},{"key":"2341_CR43","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00125-016-3965-9","volume":"59","author":"YH Lee","year":"2016","unstructured":"Lee YH, Wang M-Y, Yu X-X, Unger RH. Glucagon is the key factor in the development of diabetes. Diabetologia. 2016;59:1372\u20135.","journal-title":"Diabetologia"},{"key":"2341_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00592-011-0339-0","volume":"50","author":"G Bardini","year":"2011","unstructured":"Bardini G, Dicembrini I, Rotella CM, Giannini S. Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. Acta Diabetol. 2011;50:277\u201381.","journal-title":"Acta Diabetol"},{"key":"2341_CR45","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1161\/ATVBAHA.112.300135","volume":"32","author":"MG Sorci-Thomas","year":"2012","unstructured":"Sorci-Thomas MG, Thomas MJ. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. ATVB. 2012;32:2561\u20135.","journal-title":"ATVB"},{"key":"2341_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6668506","volume":"2021","author":"BA Di Bartolo","year":"2021","unstructured":"Di Bartolo BA, Cartland SP, Genner S, Manuneedhi Cholan P, Vellozzi M, Rye K-A. HDL improves cholesterol and glucose homeostasis and reduces atherosclerosis in diabetes-associated atherosclerosis. J Diabetes Res. 2021;2021:1\u201310.","journal-title":"J Diabetes Res"},{"key":"2341_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrendo.2011.235","volume":"8","author":"BG Drew","year":"2012","unstructured":"Drew BG, Rye K-A, Duffy SJ, Barter P, Kingwell BA. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol. 2012;8:237\u201345.","journal-title":"Nat Rev Endocrinol"},{"key":"2341_CR48","doi-asserted-by":"publisher","first-page":"978745","DOI":"10.3389\/fendo.2022.978745","volume":"13","author":"D Wei","year":"2022","unstructured":"Wei D, Marrachelli VG, Melgarejo JD, Liao C-T, Janssens S, Verhamme P, et al. Lipoprotein profiles of fat distribution and its association with insulin sensitivity. Front Endocrinol. 2022;13:978745.","journal-title":"Front Endocrinol"},{"key":"2341_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12944-018-0822-5","volume":"17","author":"S Tanaka","year":"2018","unstructured":"Tanaka S, Fujioka Y, Tsujino T, Ishida T, Hirata K. Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population. Lipids Health Dis. 2018;17:180.","journal-title":"Lipids Health Dis"},{"key":"2341_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2012.12.004","volume":"418","author":"IC Dos Santos-Weiss","year":"2013","unstructured":"Dos Santos-Weiss IC, R\u00e9a RR, Fadel-Picheth CM, et al. The plasma logarithm of the triglyceride\/HDL-cholesterol ratio is a predictor of low risk gestational diabetes in early pregnancy. Clin Chim Acta. 2013;418:1\u20134.","journal-title":"Clin Chim Acta"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02341-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:02:01Z","timestamp":1720202521000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02341-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2341"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02341-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by the Institutional Review Board at Seoul National University Boramae Medical Center and the Public Institutional Review Board of the Korean Ministry of Health and Welfare. The studies performed in line with the Declaration of Helsinki, and before enrollment, all participants supplied informed permission in writing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}